Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine · 11.09.2025 · 393 (10) · 961-972
DOI: 10.1056/nejmoa2505927 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 11.09.2025. Verfasst von Milind Y Desai und 25 weiteren Autor:innen. Beteiligte Einrichtung: Hypertrophic Cardiomyopathy Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Stroke Volume, Benzylamines. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Bristol Myers Squibb Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hypertrophic Cardiomyopathy Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland.
- Cleveland Clinic Coordinating Center for Clinical Research, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland.
- Department of Cardiology, University of Pennsylvania, Philadelphia.
- Department of Cardiology, University of, California, San Francisco, San Francisco.
- Department of Cardiology, Meyer Children's Hospital, IRCCS, Florence, Italy.
- Department of Cardiology, Hospital Universitario Puerta de Hierro, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, and Centr…
ORCID-Profile: Milind Y Desai, Iacopo Olivotto, Perry Elliott, Olga Azevedo, Steven E Nissen
Förderung
- Bristol Myers Squibb Foundation
Zitieren
APA
Desai, M. Y., Owens, A. T., Abraham, T., Olivotto, I., Garcia-Pavia, P., Lopes, R. D., Elliott, P., Fernandes, F., Verheyen, N., Maier, L., Meder, B., Azevedo, O., Kitaoka, H., Wolski, K., Wang, Q., Jaber, W., Mitchell, L., Myers, J., Rano, T., …, & ODYSSEY-HCM Investigators (2025). Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine, 393(10), 961-972. https://doi.org/10.1056/nejmoa2505927
Vancouver
Desai MY, Owens AT, Abraham T, Olivotto I, Garcia-Pavia P, Lopes RD, et al. Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine. 2025;393(10):961-972. doi:10.1056/nejmoa2505927
BibTeX
@article{Desai2025,
author = {Desai, Milind Y and Owens, Anjali T and Abraham, Theodore and Olivotto, Iacopo and Garcia-Pavia, Pablo and Lopes, Renato D and Elliott, Perry and Fernandes, Fabio and Verheyen, Nicolas and Maier, Lars and Meder, Benjamin and Azevedo, Olga and Kitaoka, Hiroaki and Wolski, Kathy and Wang, Qiuqing and Jaber, Wael and Mitchell, Lisa and Myers, Jonathan and Rano, Thomas and Gong, Zhiqun and Zhong, Yue and Carter-Bonanza, Suzanne and Florea, Victoria and Aronson, Ron and Nissen, Steven E and ODYSSEY-HCM Investigators, ODYSSEY-HCM Investigators},
title = {Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {10},
pages = {961--972},
doi = {10.1056/nejmoa2505927}
}
EUVIMED